Crucible Therapeutics Limited
Research and experimental development on biotechnology · Sheffield
ActiveUnited KingdomIncorporated 2023Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2026-02-28
IXBRL · 111 source facts · 16 selected values
Validation findingsXBRL valid
Accounts to 2026-02-28
IXBRL · 111 source facts · 16 selected values
Validation findings
XBRL valid
- Reporting period
- 2025-03-01 to 2026-02-28
- Extraction status
- complete
- Numeric facts
- 52
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2025-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod223_4300_14690230_20260228
- Source archive
- Accounts_Bulk_Data-2026-09-04.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Registered details
14690230- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2023-02-27
- Jurisdiction
- —
- Registered office
- THE INNOVATION CENTRE, 217 PORTOBELLO, SHEFFIELD, S1 4DP, ENGLAND
Classification
1 SIC codes72110
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
1 matched grantsTargeting RNA nuclear export: A disease-modifying treatment for ALS/FTDLeadLiveInnovate UK · Collaborative R&D · 2025-05-01 – 2027-04-30 · with 1 other participant£1,109,150awarded
Targeting RNA nuclear export: A disease-modifying treatment for ALS/FTDLeadLive
Innovate UK · Collaborative R&D · 2025-05-01 – 2027-04-30 · with 1 other participant
£1,109,150
awarded
Crucible Therapeutics Limitedlead£1,109,150